- Home
- KMDA vs CLPT Comparison
KMDA vs CLPT Comparison
Compare KMDA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- CLPT
- Stock Information
- Founded
- KMDA 1990
- CLPT 1998
- Country
- KMDA Israel
- CLPT United States
- Employees
- KMDA N/A
- CLPT N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- KMDA Health Care
- CLPT Health Care
- Exchange
- KMDA Nasdaq
- CLPT Nasdaq
- Market Cap
- KMDA 349.6M
- CLPT 412.7M
- IPO Year
- KMDA N/A
- CLPT N/A
- Fundamental
- Price
- KMDA $7.16
- CLPT $15.04
- Analyst Decision
- KMDA Strong Buy
- CLPT Strong Buy
- Analyst Count
- KMDA 2
- CLPT 2
- Target Price
- KMDA $14.50
- CLPT $12.00
- AVG Volume (30 Days)
- KMDA 142.0K
- CLPT 198.6K
- Earning Date
- KMDA 03-05-2025
- CLPT 03-11-2025
- Dividend Yield
- KMDA N/A
- CLPT N/A
- EPS Growth
- KMDA 124.29
- CLPT N/A
- EPS
- KMDA 0.27
- CLPT N/A
- Revenue
- KMDA $158,380,000.00
- CLPT $30,429,000.00
- Revenue This Year
- KMDA $15.81
- CLPT $35.56
- Revenue Next Year
- KMDA $5.79
- CLPT $21.86
- P/E Ratio
- KMDA $26.36
- CLPT N/A
- Revenue Growth
- KMDA 4.52
- CLPT 36.34
- 52 Week Low
- KMDA $4.74
- CLPT $5.11
- 52 Week High
- KMDA $8.00
- CLPT $17.47
- Technical
- Relative Strength Index (RSI)
- KMDA 70.04
- CLPT 51.20
- Support Level
- KMDA $7.00
- CLPT $14.75
- Resistance Level
- KMDA $8.00
- CLPT $15.93
- Average True Range (ATR)
- KMDA 0.31
- CLPT 0.78
- MACD
- KMDA 0.06
- CLPT -0.18
- Stochastic Oscillator
- KMDA 60.93
- CLPT 33.78
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.